Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice? (Q52531799)

2 May 2018

review article

1 reference

title

Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice? (English)

1 reference

2 May 2018

author name string

Krause BR

series ordinal

1

1 reference

2 May 2018

Princen HM

series ordinal

2

1 reference

2 May 2018

publication date

1 September 1998

1 reference

2 May 2018

published in

Atherosclerosis

1 reference

2 May 2018

volume

140

1 reference

2 May 2018

issue

1

1 reference

2 May 2018

page(s)

15-24

1 reference

2 May 2018

CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Comparison of lifibrol to other lipid-regulating agents in experimental animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Studies on rat liver phosphatidate phosphohydrolase and plasma lipids: effect of HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Influence of mevinolin on experimental atherosclerosis in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

The effects of mevinolin on serum cholesterol levels of rabbits with endogenous hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Catabolism of low density lipoproteins by perfused rabbit livers: cholestyramine promotes receptor-dependent hepatic catabolism of low density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Turnover of 125I-VLDL and 131I-LDL apolipoprotein B in rabbits fed diets containing casein or soy protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

ACAT inhibition decreases LDL cholesterol in rabbits fed a cholesterol-free diet. Marked changes in LDL cholesterol without changes in LDL receptor mRNA abundance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Comparative effects of HMG-CoA reductase inhibitors on apo B production in the casein-fed rabbit: atorvastatin versus lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Dissociation between cholesterol secretion and plasma lipid transfer activity in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Effects of MK-733, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, on absorption and excretion of [3H]cholesterol in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Lovastatin inhibits diet induced atherosclerosis in F1B golden Syrian hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Lovastatin is hypertriglyceridemic in Syrian golden hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Effects of gemfibrozil administration on very low density lipoprotein receptor mRNA levels in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

1.P.194 Thiazolidinediones exert a hypotriglyceridemic effect by a distinct, but complementary mechanism relative to fibrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Variations in cholesterol management practices of U.S. physicians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Evaluation of the lipid-lowering activity of AY-25,712 in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Effects of nicotinic acid on serum and tissue cholesterol in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

The effect of cholestyramine on liver HMG-CoA reductase and cholesterol 7 alpha-hydroxylase in various laboratory animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Effects of cholestyramine on lipoprotein levels and metabolism in Syrian hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

SK&F 97426-A a more potent bile acid sequestrant and hypocholesterolaemic agent than cholestyramine in the hamster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Doxazosin and cholestyramine similarly decrease fatty streak formation in the aortic arch of hyperlipidemic hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

EFFECT OF CHOLESTYRAMINE, A BILE ACID-BINDING POLYMER ON PLASMA CHOLESTEROL AND FECAL BILE ACID EXCRETION IN THE RAT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. CI-1011: an acyl sulfamate with unique cholesterol-lowering activity in animals fed noncholesterol-supplemented diets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Effects of the ACAT inhibitor CL 277,082 on cholesterol metabolism in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

ACAT inhibitors as antiatherosclerotic agents: compounds and mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

The emergence of mouse models of atherosclerosis and their relevance to clinical research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Atherosclerosis and the mouse: a decade of experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Effects of fenofibrate, gemfibrozil and nicotinic acid on plasma lipoprotein levels in normal and hyperlipidemic mice. A proposed model for drug screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

The effects of cholestyramine on high density lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Effects of estrus cycle, ovariectomy, and treatment with estrogen, tamoxifen, and progesterone on apolipoprotein(a) gene expression in transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Effect of gemfibrozil versus lovastatin on increased serum lipoprotein(a) levels of patients with hypercholesterolemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Effect of the Antioxidant N,N′ -Diphenyl 1,4-Phenylenediamine (DPPD) on Atherosclerosis in ApoE-Deficient Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Effect of probucol on macrophages, leading to regression of xanthomas and atheromatous vascular lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

"Tall oil"-derived phytosterols reduce atherosclerosis in ApoE-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

Secretion of cholesteryl-ester-rich lipoproteins by the perfused livers of rabbits fed a wheat-starch-casein diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900141-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(98)00141-5

1 reference

2 May 2018

PubMed ID

9733211

1 reference

2 May 2018